Theratechnologies RPE
Quel est le RPE de Theratechnologies?
Le RPE de Theratechnologies, Inc. est $1.529M
Quelle est la définition de RPE?
Le revenu par employé (RPE) est le revenu divisé par le nombre d'employés d'une organisation.
RPE des entreprises dans Health Care secteur sur TSX par rapport à Theratechnologies
Que fait Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Entreprises avec rpe similaire à Theratechnologies
- Solaris Oilfield Infrastructure Inc a RPE de $1.527M
- Muthoot Capital Services a RPE de ₨1.527M
- G5 Entertainment AB (publ) a RPE de kr1.527M
- Spotify Technology S.A a RPE de €1.528M
- The Bank of East Asia a RPE de HKD$1.528M
- Avantor a RPE de $1.529M
- Theratechnologies a RPE de $1.529M
- Eniro AB (publ) a RPE de kr1.530M
- Teck Resources a RPE de CAD$1.530M
- G-Resources a RPE de $1.530M
- Alvopetro a RPE de $1.530M
- China e-Wallet Payment a RPE de HKD$1.531M
- Putian Communication a RPE de ¥1.531M